Concepedia
Statistics
Publications
7
Citations
270
H-Index
Active since
2017
Affiliations
University of Kentucky(Current)
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Max Planck Institute of Biochemistry
Oregon Health & Science University
Ho Shin Kim is an author at University of Kentucky specializing in drug discovery, pharmacology, and pharmacy.
Publications per year
2017–2023
Blocking an N-terminal acetylation–dependent protein interaction inhibits an E3 ligase
Daniel C. Scott, Jared T. Hammill, Jaeki Min et al. · Nature Chemical Biology · 2017 · 110 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +9
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation
Jared T. Hammill, Deepak Bhasin, Daniel C. Scott et al. · Journal of Medicinal Chemistry · 2018 · 61 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +9
Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation
Ho Shin Kim, Jared T. Hammill, Daniel C. Scott et al. · Journal of Medicinal Chemistry · 2019 · 39 citations · Full text
Pharmacy, Medicinal Chemistry, Molecular Biology +15
Seeking the Elusive Long-Acting Ozonide: Discovery of Artefenomel (OZ439)
Ho Shin Kim, Jared T. Hammill, R. Kiplin Guy · Journal of Medicinal Chemistry · 2017 · 20 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +14
Improvement of Oral Bioavailability of Pyrazolo-Pyridone Inhibitors of the Interaction of DCN1/2 and UBE2M
Ho Shin Kim, Jared T. Hammill, Daniel C. Scott et al. · Journal of Medicinal Chemistry · 2021 · 17 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +13
1–5 of 7